Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01341041 · ClinicalTrials.gov registry record · Early Phase 1
Chlorine Dioxide Versus Saline for Wound Irrigation
A Early Phase 1 study, sponsored by Rhode Island Hospital.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 201
- Enrollment target
NCT01341041 is a Early Phase 1 study that has completed, run by Rhode Island Hospital. The registered enrollment target is 201 participants.
The verdict
NCT01341041, a Early Phase 1 study, has completed, sponsored by Rhode Island Hospital.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 201 participants
- Enrollment target
Study Summary
This research is being done because the investigators are trying to examine the safety and effectiveness of this wound cleaning liquid, CACD (chlorine dioxide). The investigators are trying to see if this liquid has the ability to decrease infection rates and decrease the scarring effects from the healing process. In animal studies, CACD has been shown to decrease scar formation and decrease the risk of wound infections. CACD is also used for the treatment of burns to decrease infection rates and improve wound healing. CACD is not FDA approved for this specific use, but it is FDA and USDA approved for reducing bacterial contamination on meat and food products for human consumption. In addition, an investigational drug (IND) application has been submitted to the FDA for this study. The FDA has approved the use of this solution for this study.
Interventions
- BIOLOGICAL chlorine dioxide
- BIOLOGICAL saline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 201 participants |
| Start Date | 2004-08 |
| Est. Completion | 2009-06 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01341041
The ClinicalTrials.gov registry entry for NCT01341041 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 201 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rhode Island Hospital, which has 130 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which chlorine dioxide is the first listed.
NCT01341041 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01341041 about?
NCT01341041 is a clinical study titled "Chlorine Dioxide Versus Saline for Wound Irrigation". This research is being done because the investigators are trying to examine the safety and effectiveness of this wound cleaning liquid, CACD (chlorine dioxide). The investigators are trying to see if this liquid has the ability to decrease infection rates and decrease the scarring effects from the h...
What is the current status of trial NCT01341041?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 201 participants. The study started on 2004-08. Estimated completion is 2009-06.
What interventions are being tested in trial NCT01341041?
The interventions under investigation include: chlorine dioxide (BIOLOGICAL), saline (BIOLOGICAL).
Who is sponsoring clinical trial NCT01341041?
This trial is sponsored by Rhode Island Hospital, which has 130 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.